Page 18 - Read Online
P. 18

Kenneson et al. J Transl Genet Genom 2024;8:285-97  https://dx.doi.org/10.20517/jtgg.2024.22  Page 289

               Table 1. Description of study population

                Living participants (n = 105) (104 male, 1 female)                     Mean (SD): 14.4 (13.0)
                        Age at most recent survey (years)                              Minimum: 0.05
                                                                                       Maximum: 58.3
                Deceased participants (n = 10) (all male)                              Mean (SD): 4.1 (7.0)
                        Age at death (years)                                           Minimum: 0.04
                                                                                       Maximum: 23
                All participants (n = 115) (114 male and 1 female)
                        Known family history? n (%)
                                ·Yes                                                   54 (47.0%)
                                ·No                                                    25 (21.7%)
                                ·Unsure                                                3 (2.6%)
                                ·Missing or incomplete                                 33 (28.7%)
                All participants (n = 115)
                        Geographical location:
                                ·United States                                         63 (54.8%)
                                ·Other                                                 52 (45.2%)
                All participants (n = 115)
                        Results of genetic testing:
                                ·Yes - findings = confirmed to have pathological mutations of BTHS   94 (81.7%)
                                ·Yes - findings = variant of unknown significance      2 (1.7%)
                                ·No - the healthcare provider indicated the participant does not need genetic testing   2 (1.7%)
                                ·No - the healthcare provider indicated the participant does not need genetic testing   5 (4.3%)
                                ·Unsure                                                4 (3.5%)
                        1
                                ·Missing                                               8 (7.0%)
                Living participants (n = 105)
                        Have health insurance? n (%)
                                ·Yes                                                   83 (79.0%)
                                ·No                                                    11 (10.5%)
                                ·Don’t know                                            3 (2.8%)
                                ·Missing                                               8 (7.6%)
               1
                Genetic testing was done (n = 6) or clinical diagnosis was made (n = 2), but participants did not provide a response to the question. SD: Standard
               deviation.

               Table 2. Age at presentation by first manifestation of BTHS
                                                                        Age at first manifestation
                First manifestation                      Prenatal  At birth  < 1 year  1-2 years  3-5 years  > 5 years
                Cardiomyopathy/heart failure (n = 57)    3       30     22      1        1        0
                Neutropenia/frequent infections (n = 4)  0       2      2       0        0        0
                Growth delay (n = 1)                     0       1      0       0        0        0
                Motor development delay (n = 3)          0       0      2       1        0        0
                Feeding difficulty/weight loss/failure to thrive (n = 27)  0  11  11  3  0        2
                Poor muscle tone (n = 7)                 1       2      1       0        1        2
                   1
                Other  (n = 3)                           0       2      1       0        0        0
                ANY (n = 102)                            4       48     39      5        2        4
               1
                Stroke, hypoglycemia, and carnitine deficiency. BTHS: Barth syndrome.

               Table 3. Age at diagnosis of BTHS for probands and non-probands
                                                              Age at diagnosis
                Group          Prenatal, n (%) At birth, n (%) < 1 year, n (%) 1-2 years, n (%) 3-5 years, n (%) > 5 years, n (%)
                All (n = 100)  1 (1%)       6 (6%)      36 (36%)   16 (16%)     18 (18%)     23 (23%)
                Proband only (n = 90)  0 (0%)  4 (4.4%)  33 (36.7%)  16 (17.8%)  16 (17.8%)  21 (23.3%)
                Non-probands (n = 10) 1 (10%)  2 (20%)  3 (30%)    0 (%)        2 (20%)      2 (20%)
               BTHS: Barth syndrome.
   13   14   15   16   17   18   19   20   21   22   23